Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
772
-
Total 13F shares, excl. options
-
230M
-
Shares change
-
+8.34M
-
Total reported value, excl. options
-
$9.9B
-
Value change
-
+$361M
-
Put/Call ratio
-
0.51
-
Number of buys
-
328
-
Number of sells
-
-321
-
Price
-
$43.12
Significant Holders of GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) as of Q2 2017
852 filings reported holding GSK - GLAXOSMITHKLINE PLC - SPONSORED ADR as of Q2 2017.
GLAXOSMITHKLINE PLC - SPONSORED ADR (GSK) has 772 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 230M shares
.
Largest 10 shareholders include FMR LLC (25M shares), PRICE T ROWE ASSOCIATES INC /MD/ (13.5M shares), Fisher Asset Management, LLC (12.5M shares), WELLS FARGO & COMPANY/MN (12M shares), STATE STREET CORP (10.3M shares), RENAISSANCE TECHNOLOGIES LLC (9.34M shares), ROYAL BANK OF CANADA (9.05M shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (7.85M shares), BANK OF AMERICA CORP /DE/ (7.63M shares), and Bank of New York Mellon Corp (5.86M shares).
This table shows the top 772 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.